Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gilbertson

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Neuro-Oncology|December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Acta Neuropathologica|August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor VorinostatTill Milde, Susanne Kleber, Andrey Korshunov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Establishing a Preclinical Multidisciplinary Board for Brain TumorsBirgit V Nimmervoll, Nidal Boulos, Brandon Bianski, et al.
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Nature Genetics|January 31, 2012
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasGang Wu, Alberto Broniscer, Troy A McEachron, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Journal of Neurosurgery. Spine|February 4, 2010
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshopElizabeth B Claus, May Abdel-Wahab, Peter C Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Neuro-Oncology|December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Acta Neuropathologica|August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor VorinostatTill Milde, Susanne Kleber, Andrey Korshunov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Establishing a Preclinical Multidisciplinary Board for Brain TumorsBirgit V Nimmervoll, Nidal Boulos, Brandon Bianski, et al.
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Nature Genetics|January 31, 2012
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasGang Wu, Alberto Broniscer, Troy A McEachron, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Journal of Neurosurgery. Spine|February 4, 2010
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshopElizabeth B Claus, May Abdel-Wahab, Peter C Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Pageof 24